For the Inventor, By the Inventor

Enter assignee name

Rehovot, Israel

Rosetta Genomics Ltd.

USPTO Granted Patents = 64

% Expired Patents = 48.4

CIPO Patents = 2

EPO Patents = 7

Forward Citations = 1,214

Loading Chart...

Loading Chart...

43 inventors (with patents filed for the assignee):

Itzhak Bentwich (29 out of 29 patents)

Ranit Aharonov (19 out of 26 patents)

Amir Avniel (19 out of 30 patents)

4. Yael Karov (15 out of 19 patents)

5. Noga Yerushalmi (8 out of 10 patents)

6. Nitzan Rosenfeld (8 out of 9 patents)

7. Shai Rosenwald (8 out of 8 patents)

8. Ayelet Chajut (8 out of 8 patents)

9. C Frank Bennett (6 out of 203 patents)

10. Christine Esau (6 out of 14 patents)

11. Eric G Marcusson (6 out of 31 patents)

12. Hila Benjamin (5 out of 5 patents)

13. Yael Spector (5 out of 5 patents)

14. Gila Lithwick Yanai (4 out of 4 patents)

15. Shlomit Gilad (3 out of 3 patents)

Core Competencies:

MicroRNA

Liver Cancer

Ovarian Cancer

Cancer Prognosis

Gene Expression Signature

Nucleic Acids

Tumor Classification

Heart Failure

Hematopoietic Malignancies

Mesothelioma

Viral Infections

Prostate Cancer

64 patents: Sort by Forward Citations

1. 10301627 - Targeting microRNAs for the treatment of liver cancer (2019-05-28),

2. 9988690 - Compositions and methods for prognosis of ovarian cancer (2018-06-05),

3. 9920379 - Nucleic acids related to MiR-29B-1-5P and uses thereof (2018-03-20),

4. 9914972 - Methods for lung cancer classification (2018-03-13),

5. 9890382 - Nucleic acid compositions related to MIR-138-1-3P and uses thereof (2018-02-13),

6. 9845470 - Targeting microRNAS for the treatment of liver cancer (2017-12-19),

7. 9834821 - Diagnosis and prognosis of various types of cancers (2017-12-05),

8. 9803247 - MicroRNAs expression signature for determination of tumors origin (2017-10-31),

9. 9765334 - Compositions and methods for prognosis of gastric cancer (2017-09-19),

10. 9708667 - MiRNA expression signature in the classification of thyroid tumors (2017-07-18),

11. 9650680 - MicroRNAs and uses thereof (2017-05-16),

12. 9650679 - HSA-MIR-146B-5P-related nucleic acids and uses thereof (2017-05-16),

13. 9631236 - Methods and compositions for determining heart failure or a risk of heart failure (2017-04-25),

14. 9624556 - Viral and viral associated miRNAs and uses thereof (2017-04-18),

15. 9540695 - Compositions and methods for prognosis of ovarian cancer (2017-01-10),

Rosetta Genomics Ltd., based in Rehovot, Israel, specializes in the development of microRNA-based therapeutics and diagnostics. The company focuses on leveraging microRNA technology to address critical areas in oncology, particularly liver and ovarian cancers. By utilizing gene expression signatures, Rosetta aims to enhance cancer prognosis and improve tumor classification. Additionally, the organization explores applications of its technology in other health conditions, including heart failure, positioning itself at the forefront of innovative therapeutic solutions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Rosetta Genomics Ltd.

64 Patents

#8 in Rehovot

#90 in Israel

#11,463 in the World

Rehovot, Israel

Rosetta Genomics Ltd.

Forward Citations = 1,214

43 inventors:

Itzhak Bentwich (29 out of 29 patents)

Ranit Aharonov (19 out of 26 patents)

Amir Avniel (19 out of 30 patents)

4. Yael Karov (15 out of 19 patents)

5. Noga Yerushalmi (8 out of 10 patents)

Please report any incorrect information to [email protected]

Loading…